The Research Protocol Bible
Most researchers who are not getting results are not using the wrong compounds. They are asking the wrong question at every stage of the protocol.
The Research Protocol Bible is a complete diagnostic framework for peptide and metabolic compound research — built for researchers who are already in a protocol and not seeing what they expected. It covers 36 compounds across six categories, a four-phase progression model, and seven bottleneck protocols that map every common stall to its root cause and the rational compound response. The question this guide is built to answer is not which compound should I use. It is why is what I am doing not working, and what is the next rational step.
Researchers who have been on a protocol for weeks or months, have read the forums, watched the videos, and are still not seeing what they expected — and do not know which variable is the problem.
Researchers who have added a second or third compound and cannot clearly identify what each one is contributing or which one is responsible for a side effect they are managing.
Researchers who hit a plateau, escalated the dose, and are still not moving — and suspect that dose was never the actual problem.
Anyone who wants to understand the decision logic behind compound selection, protocol construction, and bottleneck response before making moves that make the protocol harder to read rather than easier.
The guide organizes 36 compounds by research application — what problem they solve — not just by receptor class. The bottleneck sections in Chapter 4 are built around research application, which is how compound decisions actually get made in practice.
| Category | What it addresses | Includes |
|---|---|---|
| GLP-1 / GIP / Metabolic | Fat loss through appetite reduction and thermogenic output. The foundation layer every protocol starts with. | Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, Survodutide |
| GH Secretagogues | Lean mass preservation, fat mobilization, sleep and recovery optimization during a caloric deficit. | CJC-1295, Ipamorelin, Tesamorelin, HGH Frag 176-191, IGF-1 LR3 |
| Cellular energy, AMPK activation, metabolic rate reset, and fat mobilization at the plateau stage. | MOTs-c, SS-31, NAD+, AICAR, AOD-9604, 5-Amino-1MQ | |
| Tissue Repair | Injury recovery, gut lining integrity, cortisol reduction through inflammation resolution. | BPC-157, TB-500, TB-500/BPC-157 Blend, GHK-Cu, KPV |
| Cognitive and Mood | BDNF support, cortisol management, slow-wave sleep architecture — the most ignored bottlenecks. | Semax, Selank, DSIP, Epithalon, Glutathione, Thymosin Alpha-1 |
| Hormonal Support | HPG axis maintenance for male researchers on extended GLP-1 protocols past 12 weeks. | Gonadorelin, HCG |
The GLP-1 compound is doing its job. Adding metabolic or GH compounds now adds complexity without benefit. The rational move is to let the foundation work.
Intake is controlled. The scale has slowed. The limiting variable has shifted to output, not intake. Escalating GLP-1 dose here escalates the wrong mechanism.
Training is heavier. Recovery has dropped. Mitochondrial efficiency is declining from oxidative load. Adding output compounds here amplifies burnout.
Sleep has degraded. GH pulsatility has dropped. The anabolic window is cut short every night. GH secretagogues and sleep architecture support are the rational tools.
This guide gives researchers the phase logic, the bottleneck protocols, and the compound-level detail for all 36 compounds. What it cannot do is tell you which specific variable in your specific protocol is the problem right now. Two researchers at the same week, same compound, same dose, same plateau can be experiencing completely different root causes. The guide identifies the category of the problem. The Protocol Audit applies the framework to your exact situation and tells you which variable is the one.
For educational and research purposes only | Not medical advice | Not for human use guidance | Project Theo
Styled With